Transgene expression in the mouse cerebellar Purkinje cells with a minimal level of integration using long terminal repeat–modified lentiviral vectors

References

• Ailles LE, Naldini L (2002). HIV-1-derived lentiviral vectors. Curr Top Microbiol Immunol 261: 31–52.
   Google Scholar
• Apolonia L, Waddington SN, Fernandes C, Ward NJ, Bouma G, Blundell MP, Thrasher AJ, Collins MK, Philpott NJ (2007). Stable gene transfer to muscle using non-integrating lentiviral vectors. Mol Ther 15: 1947–1954.
   PubMed Web of Science ®Google Scholar
• Bokhoven M, Stephen SL, Knight S, Gevers EF, Robinson IC, Takeuchi Y, Collins MK (2009). Insertional gene activation by lentiviral and gammaretroviral vectors. J Virol 83: 283–294.
   PubMed Web of Science ®Google Scholar
• Brussel A, Delelis O, Sonigo P (2005). Alu-LTR real-time nested PCR assay for quantifying integrated HIV-1 DNA. Methods Mol Biol 304: 139–154.
   PubMedGoogle Scholar
• Follenzi A, Battaglia M, Lombardo A, Annoni A, Roncarolo MG, Naldini L (2004). Targeting lentiviral vector expression to hepatocytes limits transgene-specific immune response and establishes long-term expression of human antihemophilic factor IX in mice. Blood 103: 3700–3709.
   PubMed Web of Science ®Google Scholar
• Geraerts M, Willems S, Baekelandt V, Debyser Z, Gijsbers R (2006). Comparison of lentiviral vector titration methods. BMC Biotechnol 6: 34.
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P, Lim A, Osborne CS, Pawliuk R, Morillon E, Sorensen R, Forster A, Fraser P, Cohen JI, de Saint Basile G, Alexander I, Wintergerst U, Frebourg T, Aurias A, Stoppa-Lyonnet D, Romana S, Radford-Weiss I, Gross F, Valensi F, Delabesse E, Macintyre E, Sigaux F, Soulier J, Leiva LE, Wissler M, Prinz C, Rabbitts TH, Le Deist F, Fischer A, Cavazzana-Calvo M (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 302: 415–419.
   PubMed Web of Science ®Google Scholar
• Hanawa H, Persons DA, Nienhuis AW (2005). Mobilization and mechanism of transcription of integrated self-inactivating lentiviral vectors. J Virol 79: 8410–8421.
   Google Scholar
• Hawley RG, Lieu FH, Fong AZ, Hawley TS (1994). Versatile retroviral vectors for potential use in gene therapy. Gene Ther 1: 136–138.
   PubMed Web of Science ®Google Scholar
• Iwakuma T, Cui Y, Chang LJ (1999). Self-inactivating lentiviral vectors with U3 and U5 modifications. Virology 261: 120–132.
   PubMed Web of Science ®Google Scholar
• Karwacz K, Mukherjee S, Apolonia L, Blundell MP, Bouma G, Escors D, Collins MK, Thrasher AJ (2009). Nonintegrating lentivector vaccines stimulate prolonged T-cell and antibody responses and are effective in tumor therapy. J Virol 83: 3094–3103.
   PubMed Web of Science ®Google Scholar
• Kim VN, Mitrophanous K, Kingsman SM, Kingsman AJ (1998). Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1. J Virol 72: 811–816.
   PubMedGoogle Scholar
• Leavitt AD, Robles G, Alesandro N, Varmus HE (1996). Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection. J Virol 70: 721–728.
   PubMed Web of Science ®Google Scholar
• Li L, Olvera JM, Yoder KE, Mitchell RS, Butler SL, Lieber M, Martin SL, Bushman FD (2001). Role of the non-homologous DNA end joining pathway in the early steps of retroviral infection. EMBO J 20: 3272–3281.
   PubMed Web of Science ®Google Scholar
• Lu R, Limon A, Ghory HZ, Engelman A (2005). Genetic analyses of DNA-binding mutants in the catalytic core domain of human immunodeficiency virus type 1 integrase. J Virol 79: 2493–2505.
   PubMed Web of Science ®Google Scholar
• Masuda T, Kuroda MJ, Harada S (1998). Specific and independent recognition of U3 and U5 att sites by human immunodeficiency virus type 1 integrase in vivo. J Virol 72: 8396–8402.
   PubMed Web of Science ®Google Scholar
• Matsuda S, Mikawa S, Hirai H (1999). Phosphorylation of serine-880 in GluR2 by protein kinase C prevents its C terminus from binding with glutamate receptor-interacting protein. J Neurochem 73: 1765–1768.
   Google Scholar
• Miyoshi H, Blomer U, Takahashi M, Gage FH, Verma IM (1998). Development of a self-inactivating lentivirus vector. J Virol 72: 8150–8157.
   PubMed Web of Science ®Google Scholar
• Naldini L, Blomer U, Gage FH, Trono D, Verma IM (1996). Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci U S A 93: 11382–11388.
   PubMed Web of Science ®Google Scholar
• Nightingale SJ, Hollis RP, Pepper KA, Petersen D, Yu XJ, Yang C, Bahner I, Kohn DB (2006). Transient gene expression by nonintegrating lentiviral vectors. Mol Ther 13: 1121–1132.
   PubMed Web of Science ®Google Scholar
• Niwa H, Yamamura K, Miyazaki J (1991). Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108: 193–199.
   PubMed Web of Science ®Google Scholar
• Philippe S, Sarkis C, Barkats M, Mammeri H, Ladroue C, Petit C, Mallet J, Serguera C (2006). Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo. Proc Natl Acad Sci U S A 103: 17684–17689.
   PubMed Web of Science ®Google Scholar
• Rahim AA, Wong AM, Howe SJ, Buckley SM, Acosta-Saltos AD, Elston KE, Ward NJ, Philpott NJ, Cooper JD, Anderson PN, Waddington SN, Thrasher AJ, Raivich G (2009). Efficient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectors. Gene Ther 16: 509–520.
   PubMed Web of Science ®Google Scholar
• Reiser J, Harmison G, Kluepfel-Stahl S, Brady RO, Karlsson S, Schubert M (1996). Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc Natl Acad Sci U S A 93: 15266–15271.
   PubMed Web of Science ®Google Scholar
• Schmidt M, Schwarzwaelder K, Bartholomae C, Zaoui K, Ball C, Pilz I, Braun S, Glimm H, von Kalle C (2007). High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR). Nat Methods 4: 1051–1057.
   PubMed Web of Science ®Google Scholar
• Schnell T, Foley P, Wirth M, Munch J, Uberla K (2000). Development of a self-inactivating, minimal lentivirus vector based on simian immunodeficiency virus. Hum Gene Ther 11: 439–447.
   PubMed Web of Science ®Google Scholar
• Sherman PA, Dickson ML, Fyfe JA (1992). Human immunodeficiency virus type 1 integration protein: DNA sequence requirements for cleaving and joining reactions. J Virol 66: 3593–3601.
   PubMed Web of Science ®Google Scholar
• Takayama K, Torashima T, Horiuchi H, Hirai H (2008). Purkinje-cell-preferential transduction by lentiviral vectors with the murine stem cell virus promoter. Neurosci Lett 443: 7–11.
   Google Scholar
• Torashima T, Okoyama S, Nishizaki T, Hirai H (2006a). In vivo transduction of murine cerebellar Purkinje cells by HIV-derived lentiviral vectors. Brain Res 1082: 11–22.
   PubMedGoogle Scholar
• Torashima T, Yamada N, Itoh M, Yamamoto A, Hirai H (2006b). Exposure of lentiviral vectors to subneutral pH shifts the tropism from Purkinje cell to Bergmann glia. Eur J Neurosci 24: 371–380.
   Google Scholar
• Verma IM, Somia N (1997). Gene therapy – promises, problems and prospects. Nature 389: 239–242.
   PubMed Web of Science ®Google Scholar
• Wong LF, Azzouz M, Walmsley LE, Askham Z, Wilkes FJ, Mitrophanous KA, Kingsman SM, Mazarakis ND (2004). Transduction patterns of pseudotyped lentiviral vectors in the nervous system. Mol Ther 9: 101–111.
   PubMed Web of Science ®Google Scholar
• Woods NB, Bottero V, Schmidt M, von Kalle C, Verma IM (2006). Gene therapy: therapeutic gene causing lymphoma. Nature 440: 1123.
   PubMed Web of Science ®Google Scholar
• Yanez-Munoz RJ, Balaggan KS, MacNeil A, Howe SJ, Schmidt M, Smith AJ, Buch P, MacLaren RE, Anderson PN, Barker SE, Duran Y, Bartholomae C, von Kalle C, Heckenlively JR, Kinnon C, Ali RR, Thrasher AJ (2006). Effective gene therapy with nonintegrating lentiviral vectors. Nat Med 12: 348–353.
   PubMed Web of Science ®Google Scholar
• Zufferey R, Dull T, Mandel RJ, Bukovsky A, Quiroz D, Naldini L, Trono D (1998). Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J Virol 72: 9873–9880.
   PubMed Web of Science ®Google Scholar
• Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D (1997). Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15: 871–875.
   PubMed Web of Science ®Google Scholar